Stockhub

D. Western Therapeutics Institute, Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

21 September 2022

  • curprev 23:4023:40, 21 September 2022 95.149.241.133 talk 890 bytes +890 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == D. Western Therapeutics Institute, Inc., a biotechnology company, focuses on developing drugs to serve patients worldwide. The company offers GLANATEC, an ophthalmic solution for the treatment of glaucoma/ocular hypertension; and DW-1002, an ophthalmic surgical adjuvant for cataract surgeries, and ILM staining and peeling. It is also developing H-1337, a multikinase inhibitor that has completed Phase I/IIa clinical trials f..."
Retrieved from "https://stockhub.co/research/D._Western_Therapeutics_Institute,_Inc."